Atlas Trials

Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)

RecordFirmDate
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy (NCT03394365)Pierre Fabre Medicament2017-12-29

Track Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD) automatically

Every clearance here is in the API, with alerts when new ones post.